Robert Lorne Abel - 02 Mar 2026 Form 4 Insider Report for Schrodinger, Inc. (SDGR)

Reporting relationship: EVP, Chief Scientific Officer, Platform
Issuer ticker: SDGR
Reported as of: 02 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2026, 16:30:42 UTC
Prior SEC filing: 11 Feb 2026
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Donald Shum, as attorney-in-fact for Robert Lorne Abel

Key filing fact

Robert Lorne Abel filed Form 4 for Schrodinger, Inc. (SDGR) on 03 Mar 2026.

Key facts

This page summarizes Robert Lorne Abel's Form 4 filing for Schrodinger, Inc. (SDGR).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 16:30.

Change

Previous filing in this sequence was filed on 11 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001798179 Primary reporting owner

Abel Robert Lorne

Relationship: EVP, Chief Scientific Officer, Platform
Address: C/O SCHRODINGER, INC.,, 1540 BROADWAY, 24TH FLOOR, NEW YORK
Signature: /s/ Donald Shum, as attorney-in-fact for Robert Lorne Abel
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SDGR transaction

Common Stock

Award

Transaction value: $0
Shares: +17,130
Change %: +88%
Price: $0.000000
Shares after: 36,515
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F1

SDGR transaction

Common Stock

Award

Transaction value: $0
Shares: +20,682
Change %: +57%
Price: $0.000000
Shares after: 57,197
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SDGR transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +34,250
Change %
Price: $0.000000
Shares after: 34,250
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 34,250
Exercise price: $12.15
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 2, 2026 and will vest in equal installments on each of March 9, 2027, 2028, 2029 and 2030, subject to the reporting person's continued service with the company.

Footnote F2

Represents portion of the performance-based restricted stock units ("PRSUs") previously granted to the reporting person on March 4, 2024 and March 21, 2024, for which the compensation committee of the Issuer's board of directors certified on March 2, 2026 the level of achievement of the performance metrics for the PRSUs. The PRSUs will vest upon the filing of the Issuer's Annual Report on Form 10-K for the year ended December 31, 2026, subject to the reporting person's continued service with the company.

Footnote F3

Includes an aggregate of 52,949 unvested RSUs.

Footnote F4

The option was granted on March 2, 2026. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 2, 2027 and the remainder are scheduled to vest in equal monthly installments through March 2, 2030, subject to the reporting person's continued service with the company.

SEC remarks

EVP, Chief Scientific Officer, Platform